KR850002472A - 5-피리딜-1,3-티아졸 유도체의 제조방법 - Google Patents
5-피리딜-1,3-티아졸 유도체의 제조방법 Download PDFInfo
- Publication number
- KR850002472A KR850002472A KR1019840005499A KR840005499A KR850002472A KR 850002472 A KR850002472 A KR 850002472A KR 1019840005499 A KR1019840005499 A KR 1019840005499A KR 840005499 A KR840005499 A KR 840005499A KR 850002472 A KR850002472 A KR 850002472A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- optionally substituted
- pyridyl
- following general
- general formula
- Prior art date
Links
- RGXHFNJJWXTYFT-UHFFFAOYSA-N 5-pyridin-2-yl-1,3-thiazole Chemical class S1C=NC=C1C1=CC=CC=N1 RGXHFNJJWXTYFT-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000000547 substituted alkyl group Chemical group 0.000 claims 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical class C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000001754 anti-pyretic effect Effects 0.000 claims 1
- 230000000767 anti-ulcer Effects 0.000 claims 1
- 239000002221 antipyretic Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (2)
- 다음 일반식(Ⅱ)로 표시되는 화합물과 다음 일반식(Ⅲ)으로 표시되는 화합물을 반응 시킴을 특징으로 하는 다음 일반식(Ⅰ)로 표시되는 1,3-티아졸 유도체 또는 그의 염의 제조방법.[식중, R1은 임의로 치환된 알킬기, 알케 닐기, 아릴기, 아랄킬기, 시클로알킬기, 결합손으로서 탄소를 갖는 헤테로고리기 또는 아미노기를 나타내고, R2는 알킬기로 치환될 수 있는 피리딜기를 나타 내고, R3는 임의로 치환된 아릴기를 나타낸다.[식중, R2및 R3는 상기에 정의한 것과 같고, X는 할로겐 원자를 나타낸다.][식중, R1은 상기에 정의한 것과 같다.]
- 유효 성분으로서, 다음 식(Ⅰ)의 화합물 또는 그의 염의 효과적인 양과 제약에 수용할 수 있는 담체를 함유 함을 특징으로하는 진통, 해열, 소염 및 항궤양 제약 조성물.[식중, R1은 임의로 치환된 알킬기, 알케닐기, 아릴기, 아랄킬기, 시클로알킬기, 결합손으로서 탄소를 갖는 헤테로고리기 또는 아미노기를 나타내고, R2는 알킬기로 치환될 수 있는 피리딜기를 나타내고, R3는 임의로 치환된 페닐기를 나타낸다.]※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP77819 | 1983-04-17 | ||
JP167042 | 1983-09-09 | ||
JP16704283A JPS6058981A (ja) | 1983-09-09 | 1983-09-09 | 5−ピリジル−1,3−チアゾ−ル誘導体,その製造法およびそれを含んでなる医薬組成物 |
JP7781984A JPS6110580A (ja) | 1984-04-17 | 1984-04-17 | 5−ピリジル−1,3−チアゾ−ル誘導体,その製造法およびそれを含んでなる医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850002472A true KR850002472A (ko) | 1985-05-13 |
KR910004430B1 KR910004430B1 (ko) | 1991-06-27 |
Family
ID=26418876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840005499A KR910004430B1 (ko) | 1983-04-17 | 1984-09-08 | 5-피리딜-1,3-티아졸 유도체의 제조방법 |
Country Status (7)
Country | Link |
---|---|
US (1) | US4612321A (ko) |
EP (1) | EP0149884B1 (ko) |
KR (1) | KR910004430B1 (ko) |
AU (1) | AU567754B2 (ko) |
CA (1) | CA1255663A (ko) |
DE (1) | DE3486009T2 (ko) |
HU (1) | HU201753B (ko) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
US4725606A (en) * | 1984-07-25 | 1988-02-16 | Merck & Co., Inc. | 2-benzyl-4-(4-pyridyl)thiazoles and derivatives thereof as immunoregulants and compositions |
US4697012A (en) * | 1984-07-25 | 1987-09-29 | Merck & Co., Inc. | Morpholino pyridyl thiazole compound |
EP0199968B1 (en) * | 1985-03-27 | 1990-02-28 | Zenyaku Kogyo Kabushiki Kaisha | Thiazole derivatives |
US4650805A (en) * | 1985-12-02 | 1987-03-17 | Warner-Lambert Company | 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines and 4-(hexahydro-1-alkyl-3-pyridinyl)-2-thiazolamines having anti-psychotic activity |
USRE34242E (en) * | 1986-04-29 | 1993-05-04 | Akzo N.V. | Amino-oxazole compounds having dopaminergic activity |
GB8610432D0 (en) * | 1986-04-29 | 1986-06-04 | Akzo Nv | Amino-thiazole & oxazole derivatives |
FR2612189B1 (fr) * | 1987-03-13 | 1989-06-23 | Roussel Uclaf | Nouveaux derives de la pyridine, leur procede de preparation et les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions les renfermant |
FR2656610B1 (fr) * | 1989-12-29 | 1992-05-07 | Sanofi Sa | Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique. |
GB9027613D0 (en) * | 1990-12-20 | 1991-02-13 | Ici Plc | Fungicides |
US5493024A (en) * | 1991-04-11 | 1996-02-20 | Dowelanco | 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides |
DE4124942A1 (de) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
GB9201692D0 (en) * | 1992-01-27 | 1992-03-11 | Smithkline Beecham Intercredit | Compounds |
EP0772606A1 (en) * | 1994-07-27 | 1997-05-14 | G.D. SEARLE & CO. | Substituted thiazoles for the treatment of inflammation |
US5977125A (en) | 1994-10-31 | 1999-11-02 | Eisai Co., Ltd. | Mono-or polyenic carboxylic acid derivatives |
JP2636819B2 (ja) | 1994-12-20 | 1997-07-30 | 日本たばこ産業株式会社 | オキサゾール系複素環式芳香族化合物 |
US6388076B1 (en) * | 1995-06-19 | 2002-05-14 | Ontogen Corporation | Protein tyrosine phosphatase-inhibiting compounds |
JP3964478B2 (ja) * | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬 |
EP1027050B1 (en) * | 1997-10-27 | 2004-01-14 | Takeda Chemical Industries, Ltd. | 1,3-thiazoles as adenosine a3 receptor antagonists for the treatment of allergy, asthma and diabetes |
AU4506399A (en) * | 1998-06-05 | 1999-12-30 | Novartis Ag | Aryl pyridinyl thiazoles |
EP1180518B1 (en) | 1999-04-23 | 2007-01-17 | Takeda Pharmaceutical Company Limited | 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
EP1205478A4 (en) | 1999-08-06 | 2004-06-30 | Takeda Chemical Industries Ltd | P38MAP KINASE INHIBITORS |
CA2404384A1 (en) * | 2000-03-30 | 2001-10-11 | Takeda Chemical Industries, Ltd. | Substituted 1,3-thiazole compounds, their production and use |
CA2431171A1 (en) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
US7199124B2 (en) | 2001-02-02 | 2007-04-03 | Takeda Pharmaceutical Company Limited | JNK inhibitor |
AU2002324045C1 (en) | 2001-08-13 | 2008-05-29 | Janssen Pharmaceutica N.V. | 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases |
JP2006502236A (ja) * | 2002-09-18 | 2006-01-19 | ファイザー・プロダクツ・インク | 形質転換成長因子(tgf)阻害剤としてのトリアゾール誘導体 |
WO2004026863A1 (en) | 2002-09-18 | 2004-04-01 | Pfizer Products Inc. | Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
GB0326601D0 (en) * | 2003-11-14 | 2003-12-17 | Novartis Ag | Organic compounds |
BRPI0616655A2 (pt) | 2005-10-03 | 2011-06-28 | Ono Pharmaceutical Co | composto heterocìclico contendo nitrogênio e aplicação farmacêutica do mesmo |
US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
AU2012203026B2 (en) * | 2008-03-21 | 2014-06-12 | Novartis Ag | Novel heterocyclic compounds and uses thereof |
TWI435874B (zh) * | 2008-10-31 | 2014-05-01 | Toray Industries | 環己烷衍生物及其醫藥用途 |
CN102639513A (zh) * | 2009-12-17 | 2012-08-15 | 默克专利有限公司 | 鞘氨醇激酶抑制剂 |
CN103687484A (zh) | 2011-07-15 | 2014-03-26 | 巴斯夫欧洲公司 | 使用取代3-吡啶基噻唑化合物和衍生物防治动物害虫的灭害方法i |
US20150368236A1 (en) | 2012-12-27 | 2015-12-24 | Basf Se | 2-(pyridin-3-yl)-5-hetaryl-thiazole compounds carrying an imine or imine-derived substituent for combating invertebrate pests |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1062245B (de) * | 1957-10-17 | 1959-07-30 | Ciba Geigy | Verfahren zur Herstellung von 2-Amino-4-pyridyl-(2')-thiazol und seinen Salzen |
GB1112128A (en) * | 1965-12-22 | 1968-05-01 | Bellon Labor Sa Roger | New thiazolyl-diphenylmethane derivatives |
CH506548A (de) * | 1966-08-10 | 1971-04-30 | Serono Ist Farm | Verfahren zur Herstellung von 2-aminsubstituiertem 4,5-Diphenyl-Oxazol |
US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
US3705153A (en) * | 1969-05-14 | 1972-12-05 | Sumitomo Chemical Co | Novel thiazolyacetic acids and salts thereof |
HU168776B (ko) * | 1973-11-09 | 1976-07-28 | ||
US4197306A (en) * | 1977-06-30 | 1980-04-08 | Uniroyal, Inc. | Aryl-substituted thiazoles |
US4528291A (en) * | 1982-06-22 | 1985-07-09 | Schering Corporation | 2-(4'-Pyridinyl)-thiazole compounds and their use in increasing cardiac contractility |
US4697012A (en) * | 1984-07-25 | 1987-09-29 | Merck & Co., Inc. | Morpholino pyridyl thiazole compound |
-
1984
- 1984-08-23 EP EP84305789A patent/EP0149884B1/en not_active Expired - Lifetime
- 1984-08-23 DE DE8484305789T patent/DE3486009T2/de not_active Expired - Fee Related
- 1984-08-27 AU AU32433/84A patent/AU567754B2/en not_active Ceased
- 1984-09-05 US US06/647,436 patent/US4612321A/en not_active Expired - Fee Related
- 1984-09-07 CA CA000462626A patent/CA1255663A/en not_active Expired
- 1984-09-07 HU HU843401A patent/HU201753B/hu not_active IP Right Cessation
- 1984-09-08 KR KR1019840005499A patent/KR910004430B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3486009D1 (de) | 1993-01-28 |
HUT37424A (en) | 1985-12-28 |
CA1255663A (en) | 1989-06-13 |
AU3243384A (en) | 1985-03-14 |
AU567754B2 (en) | 1987-12-03 |
EP0149884B1 (en) | 1992-12-16 |
US4612321A (en) | 1986-09-16 |
EP0149884A2 (en) | 1985-07-31 |
HU201753B (en) | 1990-12-28 |
EP0149884A3 (en) | 1986-07-30 |
KR910004430B1 (ko) | 1991-06-27 |
DE3486009T2 (de) | 1993-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850002472A (ko) | 5-피리딜-1,3-티아졸 유도체의 제조방법 | |
KR900016220A (ko) | 매크로리드 조성물 | |
KR850000406A (ko) | 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법 | |
KR840004441A (ko) | 포스포리피드 유도체의 제조방법 | |
GB1390748A (en) | Alkyl and cycloalkylthiophenylalkylaminoalkanols their salts and the preparation thereof | |
FI881950A (fi) | Hyönteisten ja punkkien karkoitteet | |
KR850004492A (ko) | 옥시캄의 엔올 에테르 유도체의 제조방법 | |
DE3665711D1 (de) | Novel guanidinomethylbenzoic acid derivatives | |
KR850006187A (ko) | 신규 히달토인(Hydantoin) 유도체의 제조방법 | |
GB1464324A (en) | 1,4-dihydropyridines and ''ocesses for their manufacture | |
KR840006482A (ko) | 디히드로피라졸로 [3,4-b]피리딘 유도체의 제조방법 | |
KR840001152A (ko) | 신규 복소환(複素環) 화합물의 제법 | |
KR850004959A (ko) | 아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스 아미드 및 카보티오 아미드의 제조방법 | |
KR850000455A (ko) | 세팔로스포린 에스테르 유도체의 제조방법 | |
KR870000296A (ko) | 신규한 이사틴 화합물의 제조방법 | |
KR850001903A (ko) | 2,6-이중치환-1,4-디하이드로피리딘 유도체의 제조방법과 이것을 포함하는 약학적 조성물 | |
GB1320484A (en) | 2,6-diaminobenzoic acid derivatives | |
KR910011839A (ko) | 이미다졸리딘 유도체, 그의 제조 방법 및 이를 함유하는 살충제 | |
KR840002821A (ko) | N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법 | |
KR840006810A (ko) | 세팔로스포린 에스테르의 제조방법 | |
KR840006238A (ko) | 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법 | |
KR920002594A (ko) | 5-이소티아졸아민 유도체 | |
KR850000456A (ko) | 세팔로스포린 에스테르의 제조방법 | |
KR890005076A (ko) | 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제 | |
KR890005068A (ko) | 에탄온 옥심 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |